Long-term outcome of using Ara-C or not in children’s APL

Long-term outcome of using Ara-C or not in children’s APL

The use of cytarabine (Ara-C) in treating acute promyelocytic leukemia (APL) is controversial. This study was conducted to demonstrate the effect of treatment with or without Ara-C on long-term event-free survival (EFS) or overall survival (OS). All patients received all-trans retinoic acid (ATRA) +...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingjin Zhang, Changwen Xue, Chao Wu, Wenyu Yang, Yao Zou, Ye Guo, Yumei Chen, Xiaojuan Chen, Xiaofan Zhu, Li Zhang
Format: Article
Language:English
Published: Wolters Kluwer Health 2025-06-01
Series:Blood Science
Online Access:http://journals.lww.com/10.1097/BS9.0000000000000225
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items